Status
Conditions
About
The purpose of this study is evaluate patients with acute myeloid leukemia (<=66 years), treated with conventional and experimental chemotherapy following allogeneic transplantation. THis patients have been enrolled from 2000 to 2011 at the Division of Hematology, Molinette University Hospital. The purpose of data collection is to assess, with retrospective analysis, the clinical outcome divided by risk class and evaluated in patients who achieve complete remission after induction therapy and consolidation.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Patients with acute myeloid leukemia (<=66 years), treated with conventional and experimental chemotherapy following allogeneic transplantation. THis patients have been enrolled from 2000 to 2011 at the Division of Hematology, Molinette University Hospital.
300 participants in 1 patient group
Loading...
Central trial contact
Benedetto Bruno, MD; Benedetto Bruno, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal